Dr. Laura Dickens earned her medical degree from Emory University School of Medicine in Atlanta, Georgia. She then completed her Internal Medicine residency and Endocrinology fellowship at the University of Chicago. She joined the faculty at the University of Chicago Section of Endocrinology in 2019.
Her clinical interests include diabetes and osteoporosis. She is the co-founder of the University of Chicago Diabetes in Pregnancy Clinic (DIPP), a centralized
specialty care program for patients with pregestational type 1 or type 2 diabetes and complex gestational diabetes in pregnancy. The DIPP program incorporates patient care, education, and research initiatives aimed at improving diabetes care in pregnancy.
At the University of Chicago, in addition to her clinical endeavors, Dr. Dickens is the Associate Program Director for the Endocrinology Fellowship. She is actively involved in research related to monogenic diabetes and quality improvement for diabetes in pregnancy.
Disparities in Diabetes in Pregnancy and the Role of Social Determinants of Health.
Disparities in Diabetes in Pregnancy and the Role of Social Determinants of Health. Curr Diab Rep. 2025 May 14; 25(1):33.
PMID: 40366501
Approach to the Patient using Diabetes Technology in Pregnancy.
Approach to the Patient using Diabetes Technology in Pregnancy. J Clin Endocrinol Metab. 2025 Jan 07.
PMID: 39775858
Bone Structural Parameters as Measured by 3-Dimensional Dual-Energy X-Ray Absorptiometry Are Superior in Black Women and Demonstrate Unique Associations With Prior Fracture Versus White Women.
Bone Structural Parameters as Measured by 3-Dimensional Dual-Energy X-Ray Absorptiometry Are Superior in Black Women and Demonstrate Unique Associations With Prior Fracture Versus White Women. Endocr Pract. 2025 Feb; 31(2):152-158.
PMID: 39521249
An Update on the Fracture Risk Assessment Tool: What Have We Learned over 15+ years?
An Update on the Fracture Risk Assessment Tool: What Have We Learned over 15+ years? Endocrinol Metab Clin North Am. 2024 Dec; 53(4):531-545.
PMID: 39448135
Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine.
Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine. Nat Med. 2023 Oct; 29(10):2438-2457.
PMID: 37794253
Endocrine Society Hypercalcemia of Malignancy Guidelines.
Endocrine Society Hypercalcemia of Malignancy Guidelines. JAMA Oncol. 2023 03 01; 9(3):430-431.
PMID: 36637830
Denosumab Discontinuation in Patients Treated for Low Bone Density and Osteoporosis.
Denosumab Discontinuation in Patients Treated for Low Bone Density and Osteoporosis. Endocrinol Metab Clin North Am. 2021 06; 50(2):205-222.
PMID: 34023039
Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum Period.
Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum Period. JAMA. 2019 May 21; 321(19):1928-1929.
PMID: 31050702
Updates in Gestational Diabetes Prevalence, Treatment, and Health Policy.
Updates in Gestational Diabetes Prevalence, Treatment, and Health Policy. Curr Diab Rep. 2019 05 09; 19(6):33.
PMID: 31073850
Management and pregnancy outcomes of women with GCK-MODY enrolled in the US Monogenic Diabetes Registry.
Management and pregnancy outcomes of women with GCK-MODY enrolled in the US Monogenic Diabetes Registry. Acta Diabetol. 2019 Apr; 56(4):405-411.
PMID: 30535721